HIV Research & Clinical Practice, Volume 13, Issue 4 (2012)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

HIV Clinical Trials, Volume 13, Issue 4 (2012)

See all volumes and issues
Vol 25, 2024 Vol 24, 2023 Vol 23, 2022 Vol 22, 2021 Vol 21, 2020 Vol 20, 2019 Vol 19, 2018 Vol 18, 2017 Vol 17, 2016 Vol 16, 2015 Vol 15, 2014 Vol 14, 2013 Volume 13, 2012 Vol 12, 2011 Vol 11, 2010 Vol 10, 2009 Vol 9, 2008 Vol 8, 2007 Vol 7, 2006 Vol 6, 2005 Vol 5, 2004 Vol 4, 2003 Vol 3, 2002 Vol 2, 2001 Vol 1, 2000
Download citations Download PDFs Download issue

Original Articles

Article
A Pilot, Prospective, Open-Label Simplification Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Once-Daily Lopinavir-Ritonavir Monotherapy in HIV-HCV Coinfected Patients: The MONOCO Study
Curtis Cooper, Charles la Porte, Harout Tossonian, John Sampalis, Nabil Ackad & Brian Conway
Pages: 179-188
Published online: 06 Jan 2015
AbstractforA Pilot, Prospective, Open-Label Simplification Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Once-Daily Lopinavir-Ritonavir Monotherapy in HIV-HCV Coinfected Patients: The MONOCO Study | References | PDF (251.3 KB)
  • 54 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access
Article
Renal Toxicity Associated With Antiretroviral Therapy
Leonardo Calza
Pages: 189-211
Published online: 06 Jan 2015
AbstractforRenal Toxicity Associated With Antiretroviral Therapy | References | PDF (295.7 KB)
  • 452 Views
  • 40 CrossRef citations
  • 0Altmetric
Free Access
Article
Bone Effects of Rosiglitazone in HIV-Infected Patients With Lipoatrophy
Allison C. Ross, Corrilynn O. Hileman, Todd T. Brown, Neal Fedarko, Norma Storer, Danielle Labbato & Grace A. McComsey
Pages: 212-221
Published online: 06 Jan 2015
AbstractforBone Effects of Rosiglitazone in HIV-Infected Patients With Lipoatrophy | References | PDF (854.1 KB)
  • 94 Views
  • 5 CrossRef citations
  • 0Altmetric
Free Access
Article
Alterations in Cerebrospinal Fluid Chemokines Are Associated With Maraviroc Exposure and In Vivo Metabolites Measurable by Magnetic Resonance Spectroscopy
Jaime H. Vera, Lucy J. Garvey, Joanna M. Allsop, Steve Kaye, Myra O. McClure, David Back, Simon D. Taylor-Robinson & Alan Winston
Pages: 222-227
Published online: 06 Jan 2015
AbstractforAlterations in Cerebrospinal Fluid Chemokines Are Associated With Maraviroc Exposure and In Vivo Metabolites Measurable by Magnetic Resonance Spectroscopy | References | PDF (166.4 KB)
  • 81 Views
  • 11 CrossRef citations
  • 0Altmetric
Free Access
Article
Efficacy of Raltegravir Versus Efavirenz When Combined With Tenofovir/ Emtricitabine in Treatment-Naïve HIV-1–Infected Patients: Week-192 Overall and Subgroup Analyses From STARTMRK
Edwin DeJesus, Jürgen K. Rockstroh, Jeffrey L. Lennox, Michael S. Saag, Adriano Lazzarin, Jing Zhao, Hong Wan, Anthony J. Rodgers, Monica L. Walker, Michael Miller, Mark J. DiNubile, Bach-Yen Nguyen, Hedy Teppler, Randi Leavitt, Peter Sklar & the STARTMRK Investigators
Pages: 228-232
Published online: 06 Jan 2015
AbstractforEfficacy of Raltegravir Versus Efavirenz When Combined With Tenofovir/ Emtricitabine in Treatment-Naïve HIV-1–Infected Patients: Week-192 Overall and Subgroup Analyses From STARTMRK | References | PDF (418.1 KB)
  • 197 Views
  • 25 CrossRef citations
  • 0Altmetric
Free Access

Explore articles